A Review of Human Studies Assessing the Efficacy of Cannabidiol for Anxiety Disorders
Anxiety disorders are the most commonly diagnosed mental disorders worldwide, and their prevalence continues to rise, leading to significant social and economic burdens. Recent interest has focused on CBD as a potential treatment. This systematic review assesses the current evidence on the efficacy...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nicolaus Copernicus University in Toruń
2025-02-01
|
| Series: | Quality in Sport |
| Subjects: | |
| Online Access: | https://apcz.umk.pl/QS/article/view/58231 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832087051266162688 |
|---|---|
| author | Kuba Borys Romańczuk Katarzyna Kamińska-Omasta Bartosz Omasta Olga Krupa Paulina Dorota Pietrukaniec Zofia Martyna Wójcik Kinga Furtak Szymon Przemysław Stolarczyk Magdalena Agata Czerska Daria Rybak |
| author_facet | Kuba Borys Romańczuk Katarzyna Kamińska-Omasta Bartosz Omasta Olga Krupa Paulina Dorota Pietrukaniec Zofia Martyna Wójcik Kinga Furtak Szymon Przemysław Stolarczyk Magdalena Agata Czerska Daria Rybak |
| author_sort | Kuba Borys Romańczuk |
| collection | DOAJ |
| description |
Anxiety disorders are the most commonly diagnosed mental disorders worldwide, and their prevalence continues to rise, leading to significant social and economic burdens. Recent interest has focused on CBD as a potential treatment. This systematic review assesses the current evidence on the efficacy of CBD in treating anxiety and related disorders, including post-traumatic stress disorder (PTSD), social anxiety disorder (SAD), and autism spectrum disorder (ASD). Unlike open-label trials prone to placebo bias, this study reviews randomized, double-blind, placebo-controlled trials. A review of literature was conducted using the Google Scholar database to gather information on "cannabidiol," specifically focusing on its relationship with "anxiety," "social anxiety disorder", "post-traumatic stress disorder” and ,,human trials." Positive outcomes were observed with 300 mg CBD doses, reducing anxiety in SAD patients, tremor in Parkinson’s disease, and anxiety in ASD and opioid-dependent individuals. Minimal improvements were noted in PTSD patients with sexual trauma. Further research is needed to clarify CBD’s therapeutic potential in diverse clinical contexts.
|
| format | Article |
| id | doaj-art-bb3ebe1d1ac24db3aea8b0749e7d8fbe |
| institution | Kabale University |
| issn | 2450-3118 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Nicolaus Copernicus University in Toruń |
| record_format | Article |
| series | Quality in Sport |
| spelling | doaj-art-bb3ebe1d1ac24db3aea8b0749e7d8fbe2025-02-06T08:24:40ZengNicolaus Copernicus University in ToruńQuality in Sport2450-31182025-02-013810.12775/QS.2025.38.58231A Review of Human Studies Assessing the Efficacy of Cannabidiol for Anxiety DisordersKuba Borys Romańczuk0https://orcid.org/0009-0007-8446-8338Katarzyna Kamińska-Omasta1https://orcid.org/0009-0002-5369-0044Bartosz Omasta2https://orcid.org/0009-0001-6685-4899Olga Krupa3https://orcid.org/0009-0008-4171-0187Paulina Dorota Pietrukaniec4https://orcid.org/0009-0009-7907-6350Zofia Martyna Wójcik5https://orcid.org/0009-0005-2940-9971Kinga Furtak6https://orcid.org/0009-0008-8356-734XSzymon Przemysław Stolarczyk7https://orcid.org/0009-0002-9507-8822Magdalena Agata Czerska8https://orcid.org/0009-0008-9509-3989Daria Rybak9https://orcid.org/0009-0004-0419-9210Independent Public Multi-specialist Healthcare Facility in Stargard 27 Wojska Polskiego street, 73-110 Stargard, Poland Dr. Tytus Chałubiński Radom Specialist Hospital, Adolfa Tochtermana 1 Street, 26-610 Radom, Poland Dr. Tytus Chałubiński Radom Specialist Hospital, Adolfa Tochtermana 1 Street, 26-610 Radom, PolandMasovian Specialist Hospital, 5 Juliana Aleksandrowicza Street, 26- 617 Radom, PolandKazimierz Pulaski University of Technology and Humanitis in Radom, Jacka Malczewskiego 29 Street, 26-600 Radom, Poland Kazimierz Pulaski University of Technology and Humanitis in Radom, Jacka Malczewskiego 29 Street, 26-600 Radom, PolandFryderyk Chopin University Clinical Hospital in Rzeszów, 35-055 Rzeszów, PolandPomeranian Medical University 1 Rybacka Street, 70-204 Szczecin, PolandIndependent Public Complex of Health Care Facilities in Kozienice, Wladyslaw Sikorski 10 Street, 26-900 Kozienice, PolandMasovian Specialist Hospital, 5 Juliana Aleksandrowicza Street, 26-617 Radom, Poland Anxiety disorders are the most commonly diagnosed mental disorders worldwide, and their prevalence continues to rise, leading to significant social and economic burdens. Recent interest has focused on CBD as a potential treatment. This systematic review assesses the current evidence on the efficacy of CBD in treating anxiety and related disorders, including post-traumatic stress disorder (PTSD), social anxiety disorder (SAD), and autism spectrum disorder (ASD). Unlike open-label trials prone to placebo bias, this study reviews randomized, double-blind, placebo-controlled trials. A review of literature was conducted using the Google Scholar database to gather information on "cannabidiol," specifically focusing on its relationship with "anxiety," "social anxiety disorder", "post-traumatic stress disorder” and ,,human trials." Positive outcomes were observed with 300 mg CBD doses, reducing anxiety in SAD patients, tremor in Parkinson’s disease, and anxiety in ASD and opioid-dependent individuals. Minimal improvements were noted in PTSD patients with sexual trauma. Further research is needed to clarify CBD’s therapeutic potential in diverse clinical contexts. https://apcz.umk.pl/QS/article/view/58231AnxietyCannabidiol (CBD)Post-traumatic stress disorder (PTSD)Social anxiety disorder (SAD)Human trials |
| spellingShingle | Kuba Borys Romańczuk Katarzyna Kamińska-Omasta Bartosz Omasta Olga Krupa Paulina Dorota Pietrukaniec Zofia Martyna Wójcik Kinga Furtak Szymon Przemysław Stolarczyk Magdalena Agata Czerska Daria Rybak A Review of Human Studies Assessing the Efficacy of Cannabidiol for Anxiety Disorders Quality in Sport Anxiety Cannabidiol (CBD) Post-traumatic stress disorder (PTSD) Social anxiety disorder (SAD) Human trials |
| title | A Review of Human Studies Assessing the Efficacy of Cannabidiol for Anxiety Disorders |
| title_full | A Review of Human Studies Assessing the Efficacy of Cannabidiol for Anxiety Disorders |
| title_fullStr | A Review of Human Studies Assessing the Efficacy of Cannabidiol for Anxiety Disorders |
| title_full_unstemmed | A Review of Human Studies Assessing the Efficacy of Cannabidiol for Anxiety Disorders |
| title_short | A Review of Human Studies Assessing the Efficacy of Cannabidiol for Anxiety Disorders |
| title_sort | review of human studies assessing the efficacy of cannabidiol for anxiety disorders |
| topic | Anxiety Cannabidiol (CBD) Post-traumatic stress disorder (PTSD) Social anxiety disorder (SAD) Human trials |
| url | https://apcz.umk.pl/QS/article/view/58231 |
| work_keys_str_mv | AT kubaborysromanczuk areviewofhumanstudiesassessingtheefficacyofcannabidiolforanxietydisorders AT katarzynakaminskaomasta areviewofhumanstudiesassessingtheefficacyofcannabidiolforanxietydisorders AT bartoszomasta areviewofhumanstudiesassessingtheefficacyofcannabidiolforanxietydisorders AT olgakrupa areviewofhumanstudiesassessingtheefficacyofcannabidiolforanxietydisorders AT paulinadorotapietrukaniec areviewofhumanstudiesassessingtheefficacyofcannabidiolforanxietydisorders AT zofiamartynawojcik areviewofhumanstudiesassessingtheefficacyofcannabidiolforanxietydisorders AT kingafurtak areviewofhumanstudiesassessingtheefficacyofcannabidiolforanxietydisorders AT szymonprzemysławstolarczyk areviewofhumanstudiesassessingtheefficacyofcannabidiolforanxietydisorders AT magdalenaagataczerska areviewofhumanstudiesassessingtheefficacyofcannabidiolforanxietydisorders AT dariarybak areviewofhumanstudiesassessingtheefficacyofcannabidiolforanxietydisorders AT kubaborysromanczuk reviewofhumanstudiesassessingtheefficacyofcannabidiolforanxietydisorders AT katarzynakaminskaomasta reviewofhumanstudiesassessingtheefficacyofcannabidiolforanxietydisorders AT bartoszomasta reviewofhumanstudiesassessingtheefficacyofcannabidiolforanxietydisorders AT olgakrupa reviewofhumanstudiesassessingtheefficacyofcannabidiolforanxietydisorders AT paulinadorotapietrukaniec reviewofhumanstudiesassessingtheefficacyofcannabidiolforanxietydisorders AT zofiamartynawojcik reviewofhumanstudiesassessingtheefficacyofcannabidiolforanxietydisorders AT kingafurtak reviewofhumanstudiesassessingtheefficacyofcannabidiolforanxietydisorders AT szymonprzemysławstolarczyk reviewofhumanstudiesassessingtheefficacyofcannabidiolforanxietydisorders AT magdalenaagataczerska reviewofhumanstudiesassessingtheefficacyofcannabidiolforanxietydisorders AT dariarybak reviewofhumanstudiesassessingtheefficacyofcannabidiolforanxietydisorders |